Factor XIII: Recommended terms and abbreviations

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 1, 2007, Pages 181-183

  Muszbek, L ^a   Ariens R A ^b   Ichinose, A ^c  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 13; CALCIUM ION; D DIMER; ENZYME PRECURSOR; FIBRIN; PROTEIN SUBUNIT; THROMBIN;

ARTICLE; CELLULAR DISTRIBUTION; DISEASE CLASSIFICATION; FLOW CYTOMETRY; HEMOSTASIS; IMMUNOHISTOLOGY; MACROPHAGE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RESEARCH; MEGAKARYOCYTE; MONOCYTE; NOMENCLATURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; THROMBOCYTE;

ABBREVIATIONS; ANIMALS; FACTOR XIII; HUMANS; ISOENZYMES; PROTEIN SUBUNITS; TERMINOLOGY;

EID: 33845525449     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02182.x     Document Type: Article

References (13)

1. Muszbek L, Yee V, Hevessy Z. Blood coagulation factor XIII: Structure and function. Thromb Res 1999; 94: 271-304.
2. Ariëns RA, Lai TS, Weisel JW, Greenberg CS, Grant PJ. Role of factor XIII in fibrin clot formation and effects of polymorphisms. Blood 2002; 100: 743-54.
3. Ichinose A. Physiopathology and regulation of factor XIII. Thromb Haemost 2001; 86: 57-65.
4. Lorand L. Factor XIII and the clotting of fibrinogen: From basic research to medicine. J Thromb Haemost 2005; 3: 1337-48.
5. Nemes Z, Thomazy V. Diagnostic significance of histiocyte related markers in malignant histiocytosis and true histiocytic lymphoma. Cancer 1988; 62: 1970-80.
6. Silverman JS, Glusac EJ. Epithelioid cell histiocytoma - histogenetic and kinetic analysis of dermal microvascular unit dendritic subpopulations. J Cutan Pathol 2003; 30: 415-22.
7. Kappelmayer J, Simon A, Katona É, SzántóA, Nagy L, Kiss A, Kiss C, Muszbek L. Coagulation factor XIII-A. A flow cytometric intracellular marker in the classification of acute myeloid leukemias. Thromb Haemost 2005; 94: 454-9.
8. 2+-related regulatory function of fibrinogen. Proc Natl Acad Sci 1978; 75: 4234-7.
9. Lorand L, Jeong JM, Radek JT, Wilson J. Human plasma factor XIII: subunit interactions and activation of zymogen. Methods Enzymol 1993; 222: 22-35.
10. Polgár J, Hidasi V, Muszbek L. Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII). Biochem J 1990; 267: 557-60.
11. Muszbek L, Polgár J, Boda Z. Platelet factor XIII becomes active without the release of activation peptide during platelet activation. Thromb Haemost 1993; 69: 282-5.
12. Muszbek L, Haramura G, Polgár J. Transformation of cellular factor XIII into an active transglutaminase in thrombin-stimulated platelets. Thromb Haemost 1995; 74: 702-5.
13. Lewis SD, Janus TJ, Lorand L, Shafer JA. Regulation of formation of FXIIIa by its fibrin substrate. Biochemistry 1985; 24: 6772-7.